Literature DB >> 19536585

Brain anomalies in maternally inherited diabetes and deafness syndrome.

I Fromont1, F Nicoli, R Valéro, O Felician, B Lebail, Y Lefur, J Mancini, V Paquis-Flucklinger, P J Cozzone, Bernard Vialettes.   

Abstract

Maternally inherited diabetes and deafness (MIDD) and myoencephalopathy, lactic acidosis, stroke-like episodes (MELAS) syndromes are characterized by the same A3243G mutation of mitochondrial DNA (mtDNA). Should there be a link between these two clinical entities, one could expect to observe minor signs of MELAS in MIDD patients. To examine this issue, extensive evaluations of brain function and imaging in patients with mitochondrial diabetes and in age-matched type 1 diabetic patients were conducted and compared. MIDD patients (nine A3243G, two T14709G) and nine age-matched type 1 diabetic patients (T1D) were submitted for evaluation of cognitive functions, brain magnetic resonance (MR) imaging, and 1H-MR spectroscopy. Three MIDD patients exhibited cerebellar ataxia. The MIDD group exhibited poorer performances in sustained attention, verbal memory working, and abstract reasoning procedures, in comparison with the T1D group. MR imaging showed cerebellar atrophy in seven out of ten MIDD patients (versus 3 mild/8 in T1D controls) and basal ganglia calcifications in one MIDD patient. No evidence of (sub)acute stroke was detected. White-matter anomalies were observed in both groups (50%). 1H-MR spectroscopy revealed a significant decrease of N-acetyl aspartate only in vermis in the MIDD group, suggesting functional defect and/or neuronal loss. Lactate was detected in cerebrospinal fluid (CSF) in two MIDD and one T1D patient. Typical manifestations of MELAS are rare in MIDD syndrome, suggesting two different clinical entities. However, cerebellum involvement as assessed by imaging and 1H-MR spectroscopy is shared by both phenotypes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19536585     DOI: 10.1007/s00415-009-5185-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

1.  Searching for A3243G mitochondrial DNA mutation in buccal mucosa in order to improve the screening of patients with mitochondrial diabetes.

Authors:  H Narbonne; D Perucca-Lostanlen; C Desnuelle; B Vialettes; A Saunières; V Paquis-Flucklinger
Journal:  Eur J Endocrinol       Date:  2001-10       Impact factor: 6.664

2.  [Test for the examination of constructional apraxia].

Authors:  A REY
Journal:  Rev Neurol (Paris)       Date:  1960-06       Impact factor: 2.607

3.  Cerebellar ataxia as atypical manifestation of the 3243A>G MELAS mutation.

Authors:  V Petruzzella; S Zoccolella; A Amati; A Torraco; P Lamberti; F Carnicella; L Serlenga; S Papa
Journal:  Clin Genet       Date:  2004-01       Impact factor: 4.438

4.  Trail Making Test A and B: normative data stratified by age and education.

Authors:  Tom N Tombaugh
Journal:  Arch Clin Neuropsychol       Date:  2004-03       Impact factor: 2.813

5.  Quantitative proton magnetic resonance spectroscopy of cerebral metabolic disturbances in patients with MELAS.

Authors:  E Wilichowski; P J Pouwels; J Frahm; F Hanefeld
Journal:  Neuropediatrics       Date:  1999-10       Impact factor: 1.947

6.  Cerebral lactic acidosis correlates with neurological impairment in MELAS.

Authors:  Kazuo Abe
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

7.  Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo.

Authors:  T E Bates; M Strangward; J Keelan; G P Davey; P M Munro; J B Clark
Journal:  Neuroreport       Date:  1996-05-31       Impact factor: 1.837

8.  Screening for dementia by memory testing.

Authors:  E Grober; H Buschke; H Crystal; S Bang; R Dresner
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

9.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

10.  Diabetes with the 3243 mitochondrial tRNALeu(UUR) mutation. Characteristic neuroimaging findings.

Authors:  Y Suzuki; T Hata; H Miyaoka; Y Atsumi; H Kadowaki; M Taniyama; T Kadowaki; M Odawara; Y Tanaka; T Asahina; K Matsuoka
Journal:  Diabetes Care       Date:  1996-07       Impact factor: 19.112

View more
  9 in total

1.  The Tip of the Iceberg in Maternally Inherited Diabetes and Deafness.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Oman Med J       Date:  2018-09

2.  Globus pallidus and substantia nigra hypointensities on T2-weighted imaging in MELAS.

Authors:  Dimitri Renard; Chantal Campello; Anne Le Floch; Giovanni Castelnovo; Guillaume Taieb
Journal:  J Neurol       Date:  2012-08-01       Impact factor: 4.849

3.  Cerebellar atrophy is common among mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Metab Brain Dis       Date:  2018-05-01       Impact factor: 3.584

4.  Eye movement and vestibular dysfunction in mitochondrial A3243G mutation.

Authors:  Sung-Hee Kim; Ziyoda Abdulkhaevna Akbarkhodjaeva; Ileok Jung; Ji-Soo Kim
Journal:  Neurol Sci       Date:  2016-04-13       Impact factor: 3.307

5.  Cognitive deficits in adult m.3243A>G- and m.8344A>G-related mitochondrial disease: importance of correcting for baseline intellectual ability.

Authors:  Heather L Moore; Thomas Kelly; Alexandra Bright; Robert H Field; Andrew M Schaefer; Alasdair P Blain; Robert W Taylor; Robert McFarland; Doug M Turnbull; Gráinne S Gorman
Journal:  Ann Clin Transl Neurol       Date:  2019-03-27       Impact factor: 4.511

6.  Convulsion and cerebellar ataxia associated with maternally inherited diabetes and deafness: a case report.

Authors:  Tomomi Imamura; Shingo Konno; Masashi Inoue; Mayumi Murata; Hiroshi Nakazora; Hideki Sugimoto; Toshiki Fujioka
Journal:  Clin Case Rep       Date:  2015-06-11

7.  Phenotypic heterogeneity in m.3243A>G mitochondrial disease: The role of nuclear factors.

Authors:  Sarah J Pickett; John P Grady; Yi Shiau Ng; Gráinne S Gorman; Andrew M Schaefer; Ian J Wilson; Heather J Cordell; Doug M Turnbull; Robert W Taylor; Robert McFarland
Journal:  Ann Clin Transl Neurol       Date:  2018-02-07       Impact factor: 4.511

Review 8.  The molecular pathology of pathogenic mitochondrial tRNA variants.

Authors:  Uwe Richter; Robert McFarland; Robert W Taylor; Sarah J Pickett
Journal:  FEBS Lett       Date:  2021-02-12       Impact factor: 3.864

9.  Systematic review of cognitive deficits in adult mitochondrial disease.

Authors:  H L Moore; A P Blain; D M Turnbull; G S Gorman
Journal:  Eur J Neurol       Date:  2019-10-22       Impact factor: 6.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.